Literature DB >> 11808944

Genetic predisposition to clinical manifestations in familial adenomatous polyposis with special reference to duodenal lesions.

Takayuki Matsumoto1, Mitsuo Lida, Yoichiro Kobori, Mitsuru Mizuno, Shotaro Nakamura, Kazuoki Hizawa, Takashi Yao.   

Abstract

OBJECTIVES: In familial adenomatous polyposis (FAP), genetic predisposition for duodenal adenomatosis has not been investigated precisely. The aim of this study was to investigate the correlation between adenomatous polyposis coli (APC) gene mutation and duodenal adenomatosis in FAP.
METHODS: APC gene mutation was determined by means of a protein truncation test in 34 patients from 25 families with FAP. The prevalence and grade of duodenal adenomatosis were compared among the proximal mutation group (exons 1-9), the distal mutation group (exons 10-15), and the undetermined groups. The correlation between the course of duodenal adenomatosis and APC gene mutation was retrospectively investigated in 19 patients.
RESULTS: The prevalence of duodenal adenomatosis was lower in the proximal mutation group (44%) than in the distal mutation (100%) and undetermined (83%) groups. In patients with positive duodenal adenomatosis, the endoscopic grade did not differ among the groups. The endoscopic grade increased in two of the four patients with the proximal mutation group (50%), in three of 10 patients with the distal mutation group (30%), and in two of five patients (40%) with the undetermined group.
CONCLUSIONS: Truncating APC gene mutation proximal to exon 9 may contribute to the less frequent development of duodenal adenomatosis in FAP, but severity and progression of duodenal adenomatosis do not seem to be determined by APC gene mutation alone.

Entities:  

Mesh:

Year:  2002        PMID: 11808944     DOI: 10.1111/j.1572-0241.2002.05434.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  16 in total

Review 1.  Prevention and management of duodenal polyps in familial adenomatous polyposis.

Authors:  L A A Brosens; J J Keller; G J A Offerhaus; M Goggins; F M Giardiello
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

Review 2.  Surveillance and management of upper gastrointestinal disease in Familial Adenomatous Polyposis.

Authors:  Michelle C Gallagher; Robin K S Phillips; Steffen Bulow
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

3.  Protein-losing enteropathy in a patient with familial adenomatous polyposis and advanced colon cancer.

Authors:  Yoshihiko Miyamoto; Naoki Muguruma; Tetsuo Kimura; Koichi Okamoto; Masahiro Sogabe; Hiroshi Miyamoto; Seiya Kohno; Masahiko Nakasono; Hiroshige Hayashi; Yoshimi Bando; Tetsuji Takayama
Journal:  Clin J Gastroenterol       Date:  2016-05-12

4.  APC mutation spectrum of Norwegian familial adenomatous polyposis families: high ratio of novel mutations.

Authors:  Per Arne Andresen; Ketil Heimdal; Kristin Aaberg; Katrine Eklo; Kristin Eklo; Sarah Ariansen; Alexandra Silye; Olav Fausa; Lars Aabakken; Stefan Aretz; Tor J Eide; Tobias Gedde-Dahl
Journal:  J Cancer Res Clin Oncol       Date:  2009-05-15       Impact factor: 4.553

5.  Identification of 5 novel germline APC mutations and characterization of clinical phenotypes in Japanese patients with classical and attenuated familial adenomatous polyposis.

Authors:  Hong Tao; Kazuya Shinmura; Hidetaka Yamada; Masato Maekawa; Satoshi Osawa; Yasuhiro Takayanagi; Kazuya Okamoto; Tomohiro Terai; Hiroki Mori; Toshio Nakamura; Haruhiko Sugimura
Journal:  BMC Res Notes       Date:  2010-11-16

Review 6.  Evaluation and management of periampullary tumors.

Authors:  William A Ross; Mike M Bismar
Journal:  Curr Gastroenterol Rep       Date:  2004-10

Review 7.  MUTYH-associated colorectal cancer and adenomatous polyposis.

Authors:  Satoru Yamaguchi; Hideo Ogata; Daisuke Katsumata; Masanobu Nakajima; Takaaki Fujii; Soichi Tsutsumi; Takayuki Asao; Kinro Sasaki; Hiroyuki Kuwano; Hiroyuki Kato
Journal:  Surg Today       Date:  2013-04-19       Impact factor: 2.549

8.  Duodenal adenomatosis in familial adenomatous polyposis.

Authors:  S Bülow; J Björk; I J Christensen; O Fausa; H Järvinen; F Moesgaard; H F A Vasen
Journal:  Gut       Date:  2004-03       Impact factor: 23.059

Review 9.  Duodenal adenoma surveillance in patients with familial adenomatous polyposis.

Authors:  Fábio Guilherme Campos; Marianny Sulbaran; Adriana Vaz Safatle-Ribeiro; Carlos Augusto Real Martinez
Journal:  World J Gastrointest Endosc       Date:  2015-08-10

10.  Impact of group IVA cytosolic phospholipase A2 gene polymorphisms on phenotypic features of patients with familial adenomatous polyposis.

Authors:  Junji Umeno; Takayuki Matsumoto; Motohiro Esaki; Yoji Kukita; Tomoko Tahira; Ritsuko Yanaru-Fujisawa; Shotaro Nakamura; Hisatomi Arima; Minako Hirahashi; Kenshi Hayashi; Mitsuo Iida
Journal:  Int J Colorectal Dis       Date:  2009-10-01       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.